SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GESSI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.407
AS - Asia 11.551
EU - Europa 9.171
SA - Sud America 1.927
AF - Africa 165
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 11
Totale 46.244
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.992
SG - Singapore 4.394
CN - Cina 3.680
IT - Italia 2.644
DE - Germania 1.813
BR - Brasile 1.632
UA - Ucraina 1.464
HK - Hong Kong 1.168
TR - Turchia 1.059
GB - Regno Unito 755
VN - Vietnam 593
FI - Finlandia 536
SE - Svezia 488
RU - Federazione Russa 454
PL - Polonia 275
FR - Francia 265
CA - Canada 199
MX - Messico 177
NL - Olanda 147
IN - India 129
AR - Argentina 124
ID - Indonesia 113
BD - Bangladesh 93
JP - Giappone 82
ZA - Sudafrica 80
ES - Italia 75
BE - Belgio 58
IQ - Iraq 53
LT - Lituania 53
EC - Ecuador 51
CZ - Repubblica Ceca 32
AT - Austria 30
CO - Colombia 28
CL - Cile 26
AE - Emirati Arabi Uniti 22
MA - Marocco 22
UZ - Uzbekistan 21
VE - Venezuela 21
PY - Paraguay 20
PK - Pakistan 16
IR - Iran 14
SA - Arabia Saudita 14
TN - Tunisia 13
KE - Kenya 12
DZ - Algeria 11
IL - Israele 11
JO - Giordania 11
NP - Nepal 11
KR - Corea 10
AU - Australia 9
BG - Bulgaria 9
PE - Perù 8
RO - Romania 8
UY - Uruguay 8
AL - Albania 7
EG - Egitto 7
EU - Europa 7
BO - Bolivia 6
IE - Irlanda 6
TW - Taiwan 6
BA - Bosnia-Erzegovina 5
CH - Svizzera 5
DO - Repubblica Dominicana 5
HN - Honduras 5
JM - Giamaica 5
LV - Lettonia 5
MY - Malesia 5
OM - Oman 5
PT - Portogallo 5
GA - Gabon 4
HR - Croazia 4
KZ - Kazakistan 4
LB - Libano 4
MK - Macedonia 4
PH - Filippine 4
SN - Senegal 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
BH - Bahrain 3
BY - Bielorussia 3
CR - Costa Rica 3
GE - Georgia 3
GT - Guatemala 3
HU - Ungheria 3
KG - Kirghizistan 3
MO - Macao, regione amministrativa speciale della Cina 3
NI - Nicaragua 3
NO - Norvegia 3
PA - Panama 3
PS - Palestinian Territory 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
AO - Angola 2
CG - Congo 2
CI - Costa d'Avorio 2
ET - Etiopia 2
GR - Grecia 2
GY - Guiana 2
IM - Isola di Man 2
LU - Lussemburgo 2
Totale 46.208
Salva come PNG Salva come JPEG
Città #
Singapore 2.533
Woodbridge 2.407
Ashburn 2.103
Fairfield 2.035
Jacksonville 1.588
Chandler 1.581
Houston 1.485
Ann Arbor 1.187
Hong Kong 1.163
Beijing 1.162
Santa Clara 1.119
Wilmington 863
Seattle 833
Cambridge 670
Izmir 517
Nanjing 489
Dallas 465
Los Angeles 400
Princeton 361
Milan 352
Ferrara 314
Munich 304
Boardman 295
Warsaw 234
New York 222
Ho Chi Minh City 208
Shanghai 190
San Diego 172
Nanchang 165
Shenyang 152
Dearborn 149
São Paulo 149
Turku 126
Tianjin 123
Hanoi 114
Mexico City 112
Addison 111
Hefei 108
London 108
Bremen 104
Falkenstein 104
Helsinki 100
Changsha 98
Hebei 98
Rome 92
Buffalo 81
Jakarta 79
Frankfurt am Main 78
Chicago 75
Jiaxing 73
Tokyo 71
Montreal 70
Brooklyn 66
Jinan 63
Bologna 61
San Mateo 60
Moscow 56
Norwalk 56
Brussels 55
Toronto 55
Florence 54
Rio de Janeiro 52
Mountain View 51
The Dalles 51
Zhengzhou 50
Kunming 49
San Francisco 49
Stockholm 48
Johannesburg 45
Boston 44
Denver 43
Falls Church 43
Orem 43
Guangzhou 41
Phoenix 41
Belo Horizonte 40
Poplar 40
Düsseldorf 38
Atlanta 37
Chennai 37
Haiphong 36
Manchester 36
Orange 36
Auburn Hills 35
Redwood City 35
Ningbo 33
Verona 32
Council Bluffs 31
Mumbai 30
Amsterdam 27
Naples 27
Philadelphia 27
Brasília 25
Porto Alegre 25
Bari 24
Washington 24
Columbus 23
Ankara 22
Biên Hòa 22
Des Moines 22
Totale 29.732
Salva come PNG Salva come JPEG
Nome #
Farmacologia cellulare e molecolare, sistemi di trasmissione e autacoidi. Trasmissione purinergica 1.300
PRIN 2007 Coordinatore Nazionale del progetto Dott. Stefania Gessi- Il recettore A3 dell’adenosina: un potenziale bersaglio per la diagnosi, prognosi e terapia del cancro colorettale 570
Pharmacology of Adenosine Receptors: The State of the Art 295
Alterazioni dei recettori alfa(2) adrenergici delle piastrine umane nell'ipertensione essenziale 265
A glance at adenosine receptors: Novel target for antitumor therapy 261
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 254
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 252
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 235
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 229
A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes 227
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 220
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields 217
The A3 adenosine receptor: history and perspectives 216
Adenosine receptors and human melanoma 215
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 213
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 211
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 210
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 203
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility 201
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 200
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 200
Adenosine receptor targeting in health and disease 199
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 196
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 196
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 195
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 195
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 195
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 193
Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells 191
Antioxidant and antiinflammatory effects of epilobium parviflorum, melilotus officinalis and cardiospermum halicacabum plant extracts in macrophage and microglial cells 191
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 190
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 190
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 190
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 184
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 184
Adenosine receptors and cancer 183
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 183
van't Hoff Based Thermodynamics 182
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 181
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 181
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 180
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 179
HIF-1 neuroprotection through erythropoietin increase in hypoxia: a role for A1 adenosine receptors 178
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 178
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 178
Pathological overproduction: the bad side of adenosine 178
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 177
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 176
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 176
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 176
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 175
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 174
Binding thermodynamics at A1 and A2A adenosine receptors 173
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 172
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats 171
Adenosine receptors in health and disease 171
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 171
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 170
3H SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes 170
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: A pharmacological and biochemical study. 170
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 170
Agonists and antagonists: Molecular mechanisms and therapeutic applications 170
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 170
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 169
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 168
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. 168
Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A3 adenosine receptors. 167
Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors 166
Therapeutic potential of adenosine receptor antagonists and agonists 166
A(2A) adenosine receptors in human peripheral blood cells 165
4-(4-Fluorobenzoyl)-1-[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]piperidine and its derivatives: Synthesis and affinity at 5-HT(2A), 5-HT(2B) and 5- HT(2C) serotonin receptors 165
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 165
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 164
[3H]MRE2029F20 a new selective antagonist radioligand for the human A2B adenosine receptors. 164
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 163
Thermodynamic analysis in drug-receptor binding: the A3 adenosine receptor 163
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour 162
Adenosine and lymphocyte regulation 162
Changes in hippocampal and cortical B1 bradykinin receptor biological activity in two experimental models of epilepsy 162
A convenient synthesis by microwave heating and pharmacological evaluation of novel benzoyltriazole and saccharine derivatives as 5-HT(1A) receptor ligands 161
Biochemical and pharmacological role of A1adenosine receptors and their modulation as novel therapeutic strategy 161
New potent and selective human adenosine A3 receptor antagonists. 161
Farmacologia cellulare e molecolare, sistemi di trasmissione. Trasmissione purinergica. 160
Binding thermodynamics of 5-HT(1A) receptor ligands 158
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2receptor antagonists/inverse agonists 158
Pulsed electromagnetic field and relief of hypoxia-induced neuronal cell death: The signaling pathway 158
A3 adenosine receptors in human neutrophils and promyelocitic HL60 cells: a pharmacological and biochemical study. 157
Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemiotherapic drugs: taxol and vindesine. 157
Adenosine receptors and cancer 157
The A3 adenosine receptor: An enigmatic player in cell biology 156
Synthesis, radiolabeling, and preliminary biological evaluation of [H-3]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl )-piperazine, a potent antagonist radioligand for the P2X(7) receptor 156
THERMODYNAMICS OF A2B ADENOSINE RECEPTOR BINDING DISCRIMINATES AGONISTIC FROM ANTAGONISTIC BEHAVIOUR 156
Hydrogen sulfide modulates the release of nitric oxide and VEGF in human keratinocytes. 156
Expression, pharmacological profile and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells by using a novel selective antagonist radioligand, [3H]MRE2029F20. 156
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 155
Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A(3) adenosine receptors in human renal cells: Implications for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells. 154
Targeting A3 and A2A adenosine receptors in the fight against cancer 154
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 153
MODULATION OF THE AKT/RAS/RAF/MEK/ERK PATHWAY BY A3 ADENOSINE RECEPTOR 153
[3H]-MRE 3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 153
Totale 19.725
Salva come PNG Salva come JPEG
Categoria #
all - tutte 207.376
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 10.656
Totale 218.032
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.443 0 0 0 0 0 445 145 471 76 563 511 232
2021/20223.182 68 328 207 157 141 135 118 174 113 266 459 1.016
2022/20233.721 360 289 119 500 617 497 183 308 461 43 202 142
2023/20242.024 181 253 100 48 230 217 101 133 51 96 100 514
2024/20257.724 188 220 612 424 973 666 314 473 1.036 864 1.071 883
2025/202610.785 2.183 823 1.824 2.718 3.007 230 0 0 0 0 0 0
Totale 46.658